Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
2020 · Cardiovascular Diabetology · 219 citations
https://doi.org/10.1186/s12933-019-0980-4
D
Dor Yadin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
560
Citations
8
h-index
8
i10-index
Dor Yadin is an academic researcher from San Diego Cardiac Center. The author has contributed to research in topics: Cardiac electrophysiology and arrhythmias & Cardiac Arrhythmias and Treatments & Cardiac pacing and defibrillation studies. The author has an h-index of 8, co-authored 12 publications.
ORCID: 0000-0001-9143-0943Papers by this author
worksRegulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’
2018 · Cardiovascular Diabetology · 164 citations
https://doi.org/10.1186/s12933-018-0754-4
<scp>SK</scp> 4 K <sup>+</sup> channels are therapeutic targets for the treatment of cardiac arrhythmias
2017 · EMBO Molecular Medicine · 39 citations
https://doi.org/10.15252/emmm.201606937
PO-04-118 MECHANISTICALLY DRIVEN APPROACH TO ATRIAL FIBRILLATION ABLATION BEYOND PVI: LOCAL HETEROGENICITY IN RECOVERY OF EXCITABILITY UNDERLIES THE SUBSTRATE FOR AF
2024 · Heart Rhythm · 0 citations
https://doi.org/10.1016/j.hrthm.2024.03.1148
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat